brilliant green has been researched along with cyclin d1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chartier, S; Grandvaux, N; Lapointe, R; Mukawera, E; Pagano, PJ; Williams, V | 1 |
1 other study(ies) available for brilliant green and cyclin d1
Article | Year |
---|---|
Redox-modulating agents target NOX2-dependent IKKε oncogenic kinase expression and proliferation in human breast cancer cell lines.
Topics: Caspase 3; Caspase 7; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclic N-Oxides; Cyclin D1; Female; Gene Expression Regulation, Neoplastic; Gentian Violet; Humans; I-kappa B Kinase; MCF-7 Cells; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Oxidation-Reduction; Quaternary Ammonium Compounds; RNA, Small Interfering; Signal Transduction; Spin Labels; Superoxides | 2015 |